Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study
Authors:
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Serious complications of pancreatoduodenectomy correlate with lower rates of adjuvant chemotherapy: Results from the recurrence after Whipple's (RAW) studyEuropean Journal of Surgical Oncology, 2023
- Diabetes, Weight Change, and Pancreatic Cancer RiskJAMA Oncology, 2020
- Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitusLangenbeck's Archives of Surgery, 2020
- Age comorbidity scores as risk factors for 90‐day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: A National Population‐Based StudyCancer Medicine, 2019
- Screening for Pancreatic CancerJAMA, 2019
- Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic CancerJournal of Gastrointestinal Surgery, 2016
- Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinomaJournal of Surgical Oncology, 2015
- Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studiesEuropean Journal of Cancer, 2011
- Impact of Diabetes Mellitus on Perioperative Outcomes after Resection for Pancreatic AdenocarcinomaJournal of the American College of Surgeons, 2010
- Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause?Clinica Chimica Acta, 2006